https://www.selleckchem.com/pr....oducts/tipranavir.ht
22; 95% CI, 0.92-5.35; P = 0.08). In addition, lasmiditan seems to result in the increase in dizziness (RR, 6.36; 95% CI, 3.00-13.46; P 0.0001) and paresthesia (RR, 5.10; 95% CI, 2.66-9.78; P 0.00001). Lasmiditan treatment provides additional benefits for pain control in patients with migraine. Lasmiditan treatment provides additional benefits for pain control in patients with migraine. The use of amobarbital in the Wada test varied between epilepsy centers, with no unified dosing or protocols available in the literature to
Me gusta
Comentario
Compartir
